Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon
The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot
Medications
Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
At 15, Autumn Fuernisen is dying. She was diagnosed at age 11 with a rare
Senate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Care
The budget package Democrats are assembling in Congress would likely provide the biggest jolt to
FDA Approves Blueprint Medicines’ Ayvakit (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses,
Pandemia eleva el número de beneficiarios de Medicaid a más de 80 millones
Las últimas cifras de inscripción al Medicaid muestran que creció de 71,3 millones de miembros
Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and
You’ve Added Your Kids to Your Health Plan. What About Mom?
SACRAMENTO — When Laura Chavez’s 74-year-old mom needed eye surgery last month, Chavez paid cash
Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications
Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues, History of Recalls
Pfizer’s management knew last year there was “a mold issue” at the Kansas facility now
FDA Approves Amondys 45
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in